FDA Approval Process
The FDA approval process is the regulatory pathway through which new drugs, biologics, and medical devices are evaluated for safety and efficacy before market authorization in the United States. Manufacturers must demonstrate that their products are both safe for human use and effective for their intended purposes through rigorous testing and documentation. The process involves multiple phases of clinical testing, data review, and administrative evaluation designed to protect public health while enabling access to beneficial medical innovations.
Standard Approval Pathways
Different product categories follow distinct approval routes. New drugs typically proceed through preclinical laboratory and animal testing, followed by three phases of human clinical trials, before submission of a New Drug Application (NDA). Biological products follow similar pathways with a Biologics License Application (BLA). Medical devices are classified by risk level, with lower-risk devices potentially requiring only 510(k) notification demonstrating substantial equivalence to existing products, while higher-risk devices require a Premarket Approval (PMA) application. The entire process can take several years and involve substantial investment in research and regulatory compliance.
Modern Operations
The FDA has begun modernizing its internal operations through adoption of advanced technologies, including agentic AI tools that assist in-house staff with data analysis, documentation review, and administrative tasks. These tools aim to improve efficiency in evaluating submissions and managing the growing volume of applications, though human regulatory scientists and reviewers remain responsible for safety and efficacy determinations.
Source Notes
- 2026-04-07: AI Powered Autonomous Social Video Content Generation and Optimization · ▶ source
- 2026-04-11: Eric Kims Perfect Dak Bulgogi Quick Korean BBQ Chicken Recipe · ▶ source
- 2026-04-28: ChatGPT · ▶ source